Home » Topics » BioWorld Science

BioWorld Science
RSS

BUB1 biallelic mutations seen to cause microcephaly and developmental delay

Jan. 26, 2022

Molecular mimicry triggers multiple sclerosis

Jan. 25, 2022

Anixa and MolGenie report in vitro data on SARS-CoV-2 protease inhibitor

Jan. 25, 2022

AB1 protein targets TP53-mutated gastrointestinal tumors

Jan. 25, 2022

ImmVira leverages viral vectors to enable CAR-T therapy for solid tumors

Jan. 25, 2022

KIN-3248 shows efficacy against tumors with clinically relevant FGFR mutations

Jan. 25, 2022

PL-8177 shows promise in preclinical models of induced colitis

Jan. 25, 2022

Qualigen to develop G4-selective transcription inhibitor from UCL for cancer

Jan. 25, 2022

CBD inhibits SARS-CoV-2 replication during early stages of infection in mice

Jan. 25, 2022

Shanghai Newsky Biotechnology identifies PLA2G7 inhibitors

Jan. 25, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...